Banco Bilbao Vizcaya Argentaria S.A. Reduces Stake in Labcorp Holdings Inc.

Spanish banking group cuts its holdings in the medical research company by over 55% in the third quarter.

Mar. 17, 2026 at 7:35am

Banco Bilbao Vizcaya Argentaria S.A., a major Spanish banking group, has reduced its stake in Labcorp Holdings Inc. (NYSE:LH) by 55.3% during the third quarter, according to a recent 13F filing with the Securities and Exchange Commission. The firm now owns 15,329 shares of the medical research company's stock, down from 34,316 shares previously.

Why it matters

Banco Bilbao Vizcaya Argentaria's decision to significantly cut its position in Labcorp could signal a shift in the bank's investment strategy or outlook on the medical research industry. As a major institutional investor, the bank's moves can influence market sentiment and potentially impact Labcorp's stock performance.

The details

According to the 13F filing, Banco Bilbao Vizcaya Argentaria sold 18,987 shares of Labcorp during the third quarter, reducing its total holdings to 15,329 shares. The bank's stake in Labcorp was valued at $4.4 million as of the end of the quarter.

  • Banco Bilbao Vizcaya Argentaria reduced its Labcorp holdings during the 3rd quarter of 2026.

The players

Banco Bilbao Vizcaya Argentaria S.A.

A major Spanish banking group that has reduced its stake in Labcorp Holdings Inc. by over 55% in the third quarter of 2026.

Labcorp Holdings Inc.

A global life sciences company that provides comprehensive clinical laboratory and drug development services.

Got photos? Submit your photos here. ›

The takeaway

Banco Bilbao Vizcaya Argentaria's significant reduction in its Labcorp holdings could signal a shift in the bank's investment strategy or outlook on the medical research industry, potentially impacting Labcorp's stock performance going forward.